Nuo Therapeutics, Inc. (AURX)
AURX Stock Price Chart
Explore Nuo Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze AURX price movements and trends.
AURX Company Profile
Discover essential business fundamentals and corporate details for Nuo Therapeutics, Inc. (AURX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Oct 2017
Employees
9.00
Website
https://www.nuot.comCEO
David E. Jorden CPA
Description
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
AURX Financial Timeline
Browse a chronological timeline of Nuo Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Mar 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 11 Aug 2025
EPS came in at -$0.01 , while revenue for the quarter reached $700.20K .
Earnings released on 4 Jun 2025
EPS came in at -$0.02 , while revenue for the quarter reached $484.38K .
Earnings released on 1 Apr 2025
EPS came in at -$0.01 , while revenue for the quarter reached $394.87K .
Earnings released on 12 Nov 2024
EPS came in at -$0.01 , while revenue for the quarter reached $370.95K .
Earnings released on 12 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $364.77K .
Earnings released on 15 May 2024
EPS came in at -$0.02 , while revenue for the quarter reached $234.58K .
Earnings released on 19 Apr 2024
EPS came in at -$0.02 , while revenue for the quarter reached $197.02K .
Earnings released on 5 Feb 2024
EPS came in at -$0.02 , while revenue for the quarter reached $232.24K .
Earnings released on 14 Aug 2023
EPS came in at -$0.02 , while revenue for the quarter reached $118.17K .
Earnings released on 15 May 2023
EPS came in at -$0.02 , while revenue for the quarter reached $61.10K .
Earnings released on 14 Apr 2023
EPS came in at -$0.02 , while revenue for the quarter reached $74.00K .
Earnings released on 4 Nov 2022
EPS came in at -$0.00 .
Earnings released on 4 Nov 2022
EPS came in at -$0.02 , while revenue for the quarter reached $38.25K .
Earnings released on 10 Aug 2022
EPS came in at -$0.02 .
Earnings released on 16 May 2022
EPS came in at -$0.01 .
Earnings released on 15 Apr 2022
EPS came in at -$0.00 .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 .
Earnings released on 30 Sept 2020
EPS came in at -$0.00 .
AURX Stock Performance
Access detailed AURX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.